Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Viatris Inc (VTRS)

Viatris Inc (VTRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,131,942
  • Shares Outstanding, K 1,209,291
  • Annual Sales, $ 11,946 M
  • Annual Income, $ -669,900 K
  • 60-Month Beta 1.48
  • Price/Sales 1.34
  • Price/Cash Flow 3.84
  • Price/Book 0.85
Trade VTRS with:

Options Overview Details

View History
  • Implied Volatility 31.84%
  • Historical Volatility 23.34%
  • IV Percentile 28%
  • IV Rank 1.86%
  • IV High 335.48% on 11/19/20
  • IV Low 26.10% on 06/29/21
  • Put/Call Vol Ratio 0.46
  • Today's Volume 3,441
  • Volume Avg (30-Day) 4,868
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 255,089
  • Open Int (30-Day) 238,670

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.86
  • Number of Estimates 5
  • High Estimate 0.90
  • Low Estimate 0.82
  • Prior Year 1.32
  • Growth Rate Est. (year over year) -34.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.20 +1.36%
on 09/20/21
15.19 -11.92%
on 09/03/21
-1.28 (-8.73%)
since 08/24/21
3-Month
13.20 +1.36%
on 09/20/21
15.25 -12.26%
on 08/10/21
-0.98 (-6.82%)
since 06/24/21

Most Recent Stories

More News
Theravance (TBPH) to Cut Workforce, Hypotension Study Fails

Theravance's (TBPH) phase III study on ampreloxetine for treating symptomatic neurogenic orthostatic hypotension fails to meet goal. The company plans to cut its workforce by 75%. Stocks falls.

GSK : 38.39 (-2.41%)
JNJ : 164.36 (-0.30%)
TBPH : 7.02 (-0.99%)
VTRS : 13.38 (+0.30%)
2 Healthcare Stocks Wall Street Predicts Will Rally by 50% or More

The COVID-19 pandemic has accelerated the pace of the global healthcare market’s growth. With the widespread adoption of digital technologies and increased healthcare spending, the industry is expected...

VTRS : 13.38 (+0.30%)
ZLAB : 119.86 (-0.84%)
Why Is Viatris (VTRS) Down 3% Since Last Earnings Report?

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

VTRS : 13.38 (+0.30%)
J&J (JNJ) Gets FDA Nod for Twice-Yearly Schizophrenia Drug

J&J (JNJ) gets FDA approval for its twice-a-year treatment option for schizophrenia patients, Invega Hafyera.

REGN : 638.90 (-1.18%)
JNJ : 164.36 (-0.30%)
TEVA : 8.95 (-1.10%)
VTRS : 13.38 (+0.30%)
Viatris Inc. to Participate in BofA Global Healthcare Conference

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at the BofA Global Healthcare Conference on . Chief Financial Officer  will answer questions...

VTRS : 13.38 (+0.30%)
Viatris Inc. to Participate in Citi's 16th Annual BioPharma Conference

/PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced the company will take part in a virtual fireside chat at Citi's 16th Annual BioPharma Conference on . Chief Executive Officer  and President...

VTRS : 13.38 (+0.30%)
Theravance (TBPH) Suffers 2nd Study Failure in Two Months

Theravance's (TBPH) mid-stage candidate, izencitinib, fails in a study evaluating it in patients with ulcerative colitis.

GSK : 38.39 (-2.41%)
JNJ : 164.36 (-0.30%)
TBPH : 7.02 (-0.99%)
VTRS : 13.38 (+0.30%)
Company News for Aug 10, 2021

Companies In The News Are: BALY, CRNC, SWAV, VTRS

SWAV : 222.56 (-2.25%)
CRNC : 103.40 (-0.49%)
BALY : 50.97 (+2.78%)
VTRS : 13.38 (+0.30%)
Viatris (VTRS) Beats on Q2 Earnings & Sales, Raises View

Viatris (VTRS) beats on Q2 earnings and sales. The company raises annual guidance.

VRTX : 183.61 (-0.80%)
HZNP : 110.37 (+0.80%)
RGEN : 323.26 (-0.29%)
VTRS : 13.38 (+0.30%)
Viatris Reports Strong Second Quarter Results

/PRNewswire/ -- 

VTRS : 13.38 (+0.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Viatris Inc. is a healthcare company. It provides access to medicines, advance sustainable operations, develop solutions and leverage to connect more people to more products and services through Global Healthcare Gateway(TM). Viatris Inc., formerly known as Mylan NV, is based in PITTSBURGH.

See More

Key Turning Points

3rd Resistance Point 13.66
2nd Resistance Point 13.57
1st Resistance Point 13.47
Last Price 13.38
1st Support Level 13.28
2nd Support Level 13.19
3rd Support Level 13.09

See More

52-Week High 18.86
Fibonacci 61.8% 16.60
Fibonacci 50% 15.90
Fibonacci 38.2% 15.20
Last Price 13.38
52-Week Low 12.94

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar